- Home
- Â /Â Charles River Laboratories
Charles River Laboratories
Stock Price
$184
2024-10-29
Market Capitalization
$9.6 B
2024-10-29
Revenue
$4 B
FY, 2025
Charles River Laboratories Summary
Company Summary
- Overview
- Charles River Laboratories International is a company that provides drug discovery and non-clinical development solutions. It offers animal diagnostic research, safety assessments, biological testing, scientific and regulatory advice, microbial detection, staffing, and other services.
- Type
- Public
- Status
- Active
- Founded
- 1947
- HQ
- Wilmington, MA, US | view all locations
- Website
- https://www.criver.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
William D. Barbo, Corporate Executive Vice President & Chief Commercial Officer
Joseph W. LaPlume, Corporate Executive Vice President, Corporate Development & Strategy
Flavia Pease, Corporate Executive Vice President & Chief Financial Officer
Operating MetricsView all
Backlog (Manufacturing)
$136M
71.7%
FY, 2021
Backlog (RMS)
$266M
58.7%
FY, 2021
Countries
20
FY, 2021
LocationsView all
78 locations detected
Wilmington, MAÂ HQ
United States
251 Ballardvale Street
Antwerp Township, MI
United States
54943 N Main St
Ashland, OH
United States
1407 George Rd
Charleston, SC
United States
1023 Wappoo Rd Ste 43B
Durham, NC
United States
4001 NC-54 Suite 3150
Fairfield, NJ
United States
30 2 Bridges Rd
Charles River Laboratories Financials
Summary Financials
- Revenue (Q1, 2026)
- $995.8M
- Gross profit (Q1, 2026)
- $294.7M
- Net income (Q1, 2026)
- ($14.8M)
- Cash (Q1, 2026)
- $191.8M
- EBIT (Q1, 2026)
- $119.9M
- Enterprise value
- $12.5B